Trinity Biotech PLC
TRIB· Nasdaq
TRIBTrinity Biotech PLC
Who holds Trinity Biotech PLC, from the managers’ Form 13F reports for the quarter ended Jun 30, 2026.
Form 13F covers managers with $100 million or more. Positions are as of the quarter end and filed up to 45 days later; the latest quarter fills in as reports land.
| Manager | Shares | Change | Value | Of portfolio | Filed |
|---|---|---|---|---|---|
| Williams & Novak, LLC | 140.5K | +30.6% | $54.6K | 0.1% | Jul 8, 2026 |
| Susquehanna International Group, LLP | 26.9K | New | $10.4K | 0% | Aug 14, 2026 |
| Moss Adams Wealth Advisors LLC | 25.7K | ±0% | $10K | 0.1% | Jul 27, 2026 |
| Inspirion Wealth Advisors, LLC | 25K | ±0% | $8.9K | 0.1% | Jul 7, 2026 |
| Raymond James Financial Inc | 20.3K | ±0% | $7.9K | 0% | Aug 14, 2026 |
| Becker Capital Management Inc | 18K | ±0% | $7K | 0.1% | Jul 31, 2026 |
| LPL Financial LLC | 17.7K | +17.5% | $6.9K | 0% | Aug 7, 2026 |
| Geode Capital Management, LLC | 12.6K | −24.3% | $4.9K | 0% | Aug 12, 2026 |
| Rhumbline Advisers | 9.4K | +68.9% | $3.6K | 0% | Aug 12, 2026 |
| Osaic Holdings, Inc. | 3.5K | New | $1.4K | 0% | Aug 14, 2026 |
| Jones Financial Companies LLLP | 3.6K | −4.2% | $1.3K | 0% | Aug 14, 2026 |
| Wells Fargo & Company | 2.5K | ±0% | $972 | 0% | Aug 14, 2026 |
| Farther Finance Advisors, LLC | 2K | ±0% | $778 | 0% | Jul 17, 2026 |
| UBS Group AG | 1.1K | +9.9% | $431 | 0% | Aug 13, 2026 |
| Hunter Associates Investment Management LLC | 661.2K | +23.3% | $251 | 0.1% | Jul 23, 2026 |
| Morgan Stanley | 400 | −0.5% | $156 | 0% | Aug 13, 2026 |
| Simplex Trading, LLC | 354 | −36.2% | $137 | 0% | Aug 12, 2026 |
| Cambridge Investment Research Advisors, Inc. | 22.3K | ±0% | $9 | 0% | Jul 27, 2026 |
| Atwood & Palmer Inc | 20 | ±0% | $8 | 0% | Jul 8, 2026 |
| CoreCap Advisors, LLC | 1 | ±0% | $0 | 0% | Jul 6, 2026 |
